Tocilizumab therapy for IL-6 increment in a patient with non-fatal severe fever with thrombocytopenia syndrome
Jeong Rae Yoo, Keun Hwa Lee, Mi-Sun Kim, Hyunjoo Oh, Sang Taek Heo
Abstract
day of admission, respectively. The patient fully recovered no tocilizumab adverse events.
Topics & Concepts
TocilizumabMedicineSevere fever with thrombocytopenia syndromeViral loadAdverse effectInterleukin 6Internal medicineRescue therapyGastroenterologyImmunologyVirusInflammationDiseaseViral Infections and VectorsFire effects on ecosystemsViral Infections and Outbreaks Research